ALSERES PHARMACEUTICALS INC /DE — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ef279873-2a26-4e26-bb66-aa94ce914aa8/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-197.3M | 1992-10-17 – 2013-12-31 | evidence 0001193125-14-137904 |
| FY 2012 | $-196.8M | 1992-10-16 – 2013-03-31 | evidence 0001193125-13-225865 |
| FY 2011 | $-195.8M | 1992-10-16 – 2012-03-31 | evidence 0001193125-12-228157 |
| FY 2010 | $-3.1M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-139930 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ALSERES PHARMACEUTICALS INC /DE — all facts · Revenue · Net Income